The Help Me GxP podcast

GxP Conversations

Join Kyle Winn and Adam Walker for practical conversations about GMP, GDP, pharmaceutical quality and the guidance behind the work.

25 episodes to explore.

Newest releases

The latest four, newest first.

EU GMP Annex 1 Explained: Sterile Manufacturing and Contamination Control - GxP Conversations Ep 2522:24

Cleanrooms & sterile manufacturing

EU GMP Annex 1 Explained: Sterile Manufacturing and Contamination Control - GxP Conversations Ep 25

EU GMP Annex 1 brings sterile manufacturing controls together, from cleanroom design and aseptic behaviour to monitoring and quality oversight. Episode 25 of GxP Conversations explores how those controls work as a system.

GxP Conversations Podcast Ep 22: What Are Biosimilars? Development, Stability and Clinical Practice19:55

Guidance & regulatory context

GxP Conversations Podcast Ep 22: What Are Biosimilars? Development, Stability and Clinical Practice

What makes a biosimilar different from a conventional generic medicine? GxP Conversations Episode 22 explores biosimilar development, stability and clinical practice, with a focus on oncology and the quality systems supporting biological medicines.

20 essential starting points

A curated selection to build your understanding. Newest releases appear above.

GMP Conversations Podcast Ep 20: Industrial Cybersecurity in GMP Manufacturing18:02

Computerised systems & data

GMP Conversations Podcast Ep 20: Industrial Cybersecurity in GMP Manufacturing

Industrial cybersecurity in GMP manufacturing affects equipment control, electronic records, data integrity and operational resilience. In this episode of GMP Conversations, we discuss how cyber weaknesses can become quality risks and how teams can manage them through the Pharmaceutical Quality System.

Keep exploring

The rest of the library, newest first.

GMP Conversations Podcast Ep 14 House of Lords Report: Medicines Security a National Priority18:18

Guidance & regulatory context

GMP Conversations Podcast Ep 14 House of Lords Report: Medicines Security a National Priority

The House of Lords Public Services Committee report Medicines security - a national priority examines medicine shortages, supply chain resilience, and the risks these issues pose to patients and the wider health system. This video explains the key themes of the report and why medicines security is now being…